Other News To Note
Thursday, February 17, 2011
Orthovita Inc., of Malvern, Pa., is launching Vitoss Bioactive Foam-2X Bone Graft Substitute (Vitoss BA2X), a nonstructural bone void filler for use in the pelvis, extremities and posterolateral spine. Vitoss BA2X contains Orthovita's Vitoss beta-tricalcium phosphate scaffold and Kensey Nash Corp.'s proprietary collagen material. Along with royalties, Orthovita will pay Kensey Nash, of Exton, Pa., to manufacture the product.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.